Elliott B. Grossbard

2012

In 2012, Elliott B. Grossbard earned a total compensation of $1.6M as Executive Vice President, Chief Medical Officer at Rigel Pharmaceuticals, a 42% increase compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$239,262
Option Awards$827,130
Salary$503,709
Other$5,148
Total$1,575,249

Grossbard received $827.1K in option awards, accounting for 53% of the total pay in 2012.

Grossbard also received $239.3K in non-equity incentive plan, $503.7K in salary and $5.1K in other compensation.

Rankings

In 2012, Elliott B. Grossbard's compensation ranked 4,390th out of 11,487 executives tracked by ExecPay. In other words, Grossbard earned more than 61.8% of executives.

ClassificationRankingPercentile
All
4,390
out of 11,487
62nd
Division
Manufacturing
1,521
out of 4,253
64th
Major group
Chemicals And Allied Products
347
out of 1,198
71st
Industry group
Drugs
214
out of 920
77th
Industry
Pharmaceutical Preparations
165
out of 700
76th
Source: SEC filing on March 30, 2015.

Grossbard's colleagues

We found four more compensation records of executives who worked with Elliott B. Grossbard at Rigel Pharmaceuticals in 2012.

2012

James Gower

Rigel Pharmaceuticals

Chief Executive Officer

2012

Donald Payan

Rigel Pharmaceuticals

Executive Vice President, President of Discovery and Research

2012

Raul Rodriguez

Rigel Pharmaceuticals

Chief Executive Officer

2012

Ryan Maynard

Rigel Pharmaceuticals

Chief Financial Officer

In-depth

You may also like